Abstract
This review highlights the need for continuous monitoring devices (CGM) in comparison with the self-monitoring of blood glucose (SMBG), with a little focus on various marketed CGM devices. It provides significant attention to the latest generations of glucose biosensors and enzymatic glucose bio sensing. The advantages and limitations of various physiological samples for continuous glucose monitoring are discussed. Also, discussed are the use of semipermeable membranes to improve the biosensor’s sensitivity and selectivity while retaining its stability.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Health Technology and Innovation
Paper Title
Journal
Date
